MBX Biosciences, Inc. MBX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$86.61M-17.9% | -$86.97M-40.5% | -$80.5M-45.9% | -$77.02M-63.2% | -$73.47M-88.6% | ||
| $324K-3.3% | $337K+10.1% | $335K+15.9% | $335K+15.9% | $335K— | ||
| $12.32M+127% | $8.68M+66.2% | $7.51M+58.0% | $6.46M— | $5.44M— | ||
| -$77.48M-16.2% | -$79.95M-46.2% | -$77.69M-56.0% | -$70.81M— | -$66.65M— | ||
| $2.34M+270% | $1.93M+121% | $1.23M+46.7% | $886K— | $631K— | ||
| -$184.03M-6.5% | -$83.71M+47.9% | -$21.08M+82.8% | -$138.92M— | -$172.8M— | ||
| $277.02M+18.4% | $189.59M-19.1% | $189.15M-19.3% | $237.14M— | $234.06M— | ||
| —— | —— | —— | —— | —— | ||
| -$79.82M-18.6% | -$81.88M-47.4% | -$78.91M-55.9% | -$71.7M— | -$67.28M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does MBX Biosciences, Inc. generate?
- MBX Biosciences, Inc. (MBX) generated -$77.5M in operating cash flow over the trailing twelve months.
- What is MBX Biosciences, Inc.'s free cash flow?
- After $2.3M of capital expenditures, MBX Biosciences, Inc.'s free cash flow was -$79.8M over the trailing twelve months, down 18.6% year over year.
- Where does MBX Biosciences, Inc.'s cash flow data come from?
- Every line is extracted from MBX Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.